|
20q
|
BCL2L1, SRC, MYBL2, PTPN1, ZNF217, BCAS1, GNAS
|
P157-20q
|
€ 1145
|
|
ALL
|
IKZF1, PAX5, ETV6, RB1, BTG1, EBF1, CDKN2A-CDKN2B, Xp22.33
|
P335-ALL-IKZF1
|
€ 1145
|
|
ALL
|
Xp22.33
|
P329-CRLF2
|
€ 1145
|
|
ALL, iAMP21
|
IAMP21, RUNX1
|
P327-iAMP21
|
€ 1145
|
|
Acute lymphoplastic leukemia (ALL), CML
|
IKZF1 7p12.2
|
P202-IKZF1 (IKAROS)
|
€ 1145
|
|
Breast tumour
|
ERBB2, BIRC5, MYC, TOP2A, ESR1, MTDH, CCND1, CCNE1, EGFR and C11orf30
|
P078-Breast tumor
|
€ 1145
|
|
CDH1 or E-cadherin
|
CDH1 16q22.1
|
P083-CDH1
|
€ 1145
|
|
Cancer
|
PTEN 10q23
|
P225-PTEN
|
€ 1145
|
|
Cancer
|
ERBB2 (HER2-NEU) 17q21.1
|
A012-ERBB2
|
€ 685
|
|
Cancer
|
ERBB2 (HER2-NEU) 17q21.1
|
P004-ERBB2
|
€ 1145
|
|
Centromeric screening
|
Centromeres
|
P181-Centromere-1
|
€ 1145
|
|
Centromeric screening
|
Centromeres
|
P182-Centromere-2
|
€ 1145
|
|
Chronic Lymphocytic Leukemia (CLL)
|
Various
|
P038-CLL-2
|
€ 1145
|
|
Chronic Lymphocytic Leukemia (CLL)
|
Various
|
P040-CLL
|
€ 1145
|
|
Chronic Lymphocytic Leukemia (CLL)
|
Various
|
P037-CLL-1
|
€ 1145
|
|
Dihydropyrimidine dehydrogenase (DPYD) deficiency
|
DPYD 1p22
|
P103-DPYD
|
€ 1145
|
|
Li-Fraumeni syndrome (LFS)
|
P53 17q13.1
|
P056-TP53
|
€ 1145
|
|
Medulloblastoma
|
Chr. 1, Chr. 4, Chr. 5, Chr. 8, Chr. 10, Chr. 20
|
P303-Medulloblastoma mix 3
|
€ 1145
|
|
Medulloblastoma
|
Chr. 6, Chr. 14, Chr. 16, Chr. 17.
|
P301-Medulloblastoma mix 1
|
€ 1145
|
|
Medulloblastoma
|
Chr. 2, Chr. 3, Chr. 7, Chr. 9
|
P302-Medulloblastoma mix 2
|
€ 1145
|
|
Mismatch repair genes (MMR)
|
MLH1, MSH2, MSH6, MLH3, MSH3
|
ME011-MMRimproved
|
€ 1145
|
|
Multiple Osteochondromas
|
EXT1 8q24, EXT2 11p12
|
P215-EXT
|
€ 1145
|
|
Myelodysplastic syndrome (MDS)
|
Chr. 5, 7, 8, 11, 12, 17, 20, 21
|
P144-MDS mix 1
|
€ 1145
|
|
Myelodysplastic syndrome (MDS)
|
Chr. 5, 7, 8, 11, 12, 17, 20, 21
|
P145-MDS mix 2
|
€ 1145
|
|
Neuroblastoma
|
2p24.1/MYCN, 2q33, 17p13/TP53, 17q
|
P252-NB mix 2
|
€ 1145
|
|
Neuroblastoma
|
1p36, 3p22/3p21.3 and 11q23
|
P251-NB mix 1
|
€ 1145
|
|
Neuroblastoma
|
Chromosomes 4, 7, 9, 12, 14
|
P253-NB mix 3
|
€ 1145
|
|
Neurofibromatosis
|
NF1 17q11.2
|
P122-NF1-area
|
€ 1145
|
|
Oligodendroglioma
|
1p, 19q
|
P088-Glioma-1
|
€ 1145
|
|
Oligodendroglioma
|
EGFR, TP53, PTEN, CDKN2A, ERBB2
|
P105-Glioma-2
|
€ 1145
|
|
Rhabdoid tumors
|
SMARCB1 22q11.2
|
P258-SMARCB1
|
€ 1145
|
|
Tumor research
|
Chromosome 8
|
P014-Chromosome 8
|
€ 1145
|
|
Tumour analysis
|
RBM14, 11q13
|
P284-RBM14-11q13basic research
|
€ 1145€ 572.50
|
|
Tumour research
|
Various
|
P006-H.C.A.-2
|
€ 1145
|
|
Tumour research
|
Various
|
P007-H.C.A.-3
|
€ 1145
|
|
Tumour research
|
various
|
P005-H.C.A.-1
|
€ 1145
|
|
Tumour suppressor genes
|
Various
|
ME004-Tumor sup.-4basic research
|
€ 1145
|
|
Tumour suppressor genes
|
Various
|
ME001-Tumor sup.-1basic research
|
€ 1145
|
|
Tumour suppressor genes
|
Various
|
ME002-Tumor sup.-2basic research
|
€ 1145
|
|
Tumour suppressor genes
|
Various
|
ME003-Tumor sup.-3basic research
|
€ 1145
|
|
Tumour-Loss
|
various
|
P294-Tumour-Lossbasic research
|
€ 1145€ 687
|
|
Tumour-gain
|
various
|
P175-Tumour-Gainbasic research
|
€ 1145€ 687
|
|
Tumours
|
various genes
|
P173-Gain-3
|
€ 1145
|
|
Tumours
|
various genes
|
P171-Gain-1
|
€ 1145
|
|
Tumours
|
various genes
|
P172-Gain-2
|
€ 1145
|
|
Tumours, Cutaneous melanoma
|
9p21, CDKN2A, CDKNA2B
|
ME024-9p21
|
€ 1145
|
|
Tumours, solid
|
EGFR 7p11
|
P315-EGFR
|
€ 1145
|
|
Uveal Melanoma
|
1p, 3, 6p, 8q (MYC region)
|
P027-Uveal
|
€ 1145
|
|
Von Hippel-Lindau Syndrome
|
VHL, 3p25
|
P016-VHL
|
€ 1145
|